Unused Period Products and Mold: What Experts Say
Social media posts showing sealed, unused sanitary pads held up to light with dark, splotchy areas have raised concerns that unused period products may be contaminated with mold.
The whole archive, newest first
Social media posts showing sealed, unused sanitary pads held up to light with dark, splotchy areas have raised concerns that unused period products may be contaminated with mold.
Daylight Saving Time ends Sunday, November 2, at 2:00 a.m. Eastern, and the recurring debate about whether switching clocks twice a year benefits health continues.
A Gallup online survey of nearly 17,000 U.S. adults, conducted during the first nine months of 2025, finds the adult obesity rate has fallen as use of GLP-1 weight-loss medications has…
Open enrollment for Affordable Care Act (ACA) plans runs November 1 through January 15, 2026. Experts urge consumers to review options carefully: monthly premiums, out-of-pocket costs…
A new study published in mBio (October 23) found that about 18% of urinary tract infections (UTIs) were linked to E.
A large UK Biobank analysis found that adults who usually accumulate their daily steps in sustained walks of 15 minutes or longer had substantially lower mortality and cardiovascular…
A new, not-yet–peer-reviewed analysis finds that women who experience natural menopause earlier are more likely to develop metabolic syndrome — a cluster of risk factors that increases…
A large analysis published October 21 in The Lancet examined more than 58,000 people across 151 trials of 30 commonly prescribed antidepressants during the first eight weeks of…
A large analysis of pediatric electronic health records provides real-world evidence that introducing peanut early in infancy is associated with falling rates of peanut and other…
California has launched a state-branded insulin program meant to lower costs for people with diabetes.
A Consumer Reports investigation tested 23 popular protein powders and meal-replacement shakes and found many contained troubling amounts of lead.
A combination of enzalutamide and the hormone therapy leuprolide—already used for metastatic prostate cancer—appears to extend survival when given earlier to men whose cancer returned…